Results 21 to 30 of about 4,006,128 (388)

The Study of Spray-Freeze-Drying Technique for Development of Novel Combination pMDIs, Part I: Study on the Preparation Method

Pharmaceutical Fronts, 2022
Clinically available pressurized metered-dose inhalers (pMDIs) mainly directly use micronized drugs as inhalable microparticles. Although technology for preparing pMDIs has proven to obtain clinically appropriate aerosol performance, the fine particle ...
Quan Xi, Jia-Ying Miao, Zhen Cao, Hao Wang   +3 more
doaj   +1 more source

Preparation and Study on the Single-Crystal Structure of Flurbiprofen–Salicylamide Co-crystal

Pharmaceutical Fronts, 2023
Co-crystals can improve the physicochemical properties of pharmaceutical active ingredients, and thus have great potential in improving drug performance.
Jia-Wei Hou, Yan-Qing Gong, Gang Li, Li-Wen Ma, Hong-Juan Pan, Han-Bin Shan, Jia-Liang Zhong   +6 more
doaj   +1 more source

Investigation of the Uniformity of Gel Shrinkage by Imaging Tracer Particles Using X‐Ray Microtomography

Advanced Engineering Materials, EarlyView., 2023
A novel method for tracking structural changes in gels using widely accessible microcomputed tomography is presented and validated for various hydro‐, alco‐, and aerogels. The core idea of the method is to track positions of micrometer‐sized tracer particles entrapped in the gel and relate them to the density of the gel network.
Anja Hajnal, Mimololorun Lucy Aiyelari, Martin Dirauf, Pavel Gurikov   +3 more
wiley   +1 more source

Advances in Recombinant Lipases: Production, Engineering, Immobilization and Application in the Pharmaceutical Industry

Catalysts, 2020
Lipases are one of the most used enzymes in the pharmaceutical industry due to their efficiency in organic syntheses, mainly in the production of enantiopure drugs.
F. J. Contesini, M. G. Davanço, G. Borin, Katherina García Vanegas, João Pedro Gonçalves Cirino, R. Melo, U. Mortensen, K. Hildén, D. R. Campos, P. Carvalho   +9 more
semanticscholar   +1 more source

Processing-Induced Disorder in Pharmaceutical Materials [PDF]

, 2016
This chapter focuses on the major types of pharmaceutical processing methods that have been widely reported to produce disordered material either intentionally or unintentionally.
Al-Obaidi, Alkhatib, Alonzo, Bahl, Balani, Breitenbach, Brough, Brown, Cal, Cerea, Chakraborty, Chattoraj, Chieng, Clark, Cordeiro, Cui, De Beer, Descamps, DiNunzio, Dinunzio, El-Badry, Elamin, Felton, Feng, Forster, Gazzaniga, Graeser, Guns, Gupta, He, Hu, Hu, Janssens, Kang, Karmwar, Ke, Keen, Khan, Kim, Koivisto, Lai, Laitinen, Laitinen, Lang, Lauer, Luisi, Luo, Löbmann, Löbmann, Nagy, Ng, Norrman, Otte, Otte, Passerini, Patterson, Porter, Qi, Qi, Qi, Qi, Repka, Riippi, Saerens, Sammoura, Santivarangkna, Sauer, Sauer, Sill, Sollohub, Tang, Trasi, Trasi, Van den Brande, Van Eerdenbrugh, Van Eerdenbrughand, Van Melkebeke, Vehring, Weatherley, Weuts, Willart, Willart, Willart, Williams, Windbergs, Windbergs, Wojnarowska, Yang, Zamani, Zema   +89 more
core   +1 more source

Risky Business

INNOVATIONS in Pharmacy, 2011
Type ...
Miranda Katwaru, Matthew Tobin, Vibhuti Arya   +2 more
doaj   +1 more source

Making regulation responsive to commercial interests: streamlining drug industry watchdogs [PDF]

, 2002
New prescription drugs are developed and tested for quality, safety, and efficacy by the pharmaceutical industry, and little or no drug testing is conducted by governments in modern industrialised countries.
Abraham, John
core   +2 more sources

Medicine and the pharmaceutical industry [PDF]

Developmental Medicine & Child Neurology, 2006
One privilege of working in the health service today is the enormous range of effective therapies available to us. Advances in surgical techniques, tools, and materials have been more than matched by the vast number of pharmaceutical products addressing an ever wider range of conditions. Even for conditions where treatments have been available for many
openaire   +3 more sources

Synthesis and Biological Evaluation of a Series of Novel 1-(3-((6-Fluoropyridin-3-yl)oxy)propyl)piperazines as Dopamine/Serotonin Receptor Agonists

Pharmaceutical Fronts, 2022
Evidence suggested that the use of partial dopamine D2/D3 receptor agonists may be a better choice for the treatment of Parkinson's disease (PD), and the stimulation of 5-HT1A receptors (mainly via nondopaminergic mechanisms) alleviates motor and ...
Xin-Li Du, Yan-Na Ni, Jiang-Rong Ji, Ze-Hong Wan, Zhi-Jing Hu, Yu-Qiang Ge, Jian-Qi Li, Guan Wang   +7 more
doaj   +1 more source

Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing?

Annals of Internal Medicine, 2020
BACKGROUND Financial payments from the drug industry to U.S. physicians are common. Payments may influence physicians' clinical decision making and drug prescribing.
Aaron P. Mitchell, Niti U. Trivedi, R. Gennarelli, S. Chimonas, Sara M. Tabatabai, J. Goldberg, L. Diaz, D. Korenstein   +7 more
semanticscholar   +1 more source